PK

Pavan Kumar Ambati

Active Director Director DIN 07592323
DIN 07592323 First appointment Aug 2016 Primary industry Electrnoics
Unlock full profile Investments · shareholding · contact details
Current companies 10 active board seats
Total affiliations 10 Since Aug 2016
Shareholding value •••• Premium profile

About Pavan Kumar Ambati

Data last updated:

Pavan Kumar Ambati is a Director at Biswa Pharmaceuticals Private Limited (since 2018), Director at Mokshya Retails Private Limited (since 2018) and Director at Hi-Tech Edifice Private Limited (since 2016), and holds 7 more current directorships. The companies operate in Electrnoics, Real Estate and Construction and Construction. The 5 current companies with reported revenue have a combined latest revenue of ₹32.19 Cr; the largest is Biswa Pharmaceuticals Private Limited at ₹18.36 Cr (FY 2024).

DIN 07592323
Primary Designation Director
Industry Electrnoics
First Appointment 18 Aug 2016
Oldest Company Age 30 yrs
Largest company Biswa Pharmaceuticals Private Limited · ₹18.36 Cr (FY 2024)
Combined revenue ₹32.19 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Aug 20182018₹18.36 Cr (FY 2024)Active
Mokshya Retails Private Limited U52609OR2018PTC028895
Director18 May 20182018₹7.23 Cr (FY 2024)Active
Hi-Tech Edifice Private Limited U45201OR2005PTC008402
Director18 Aug 20162005₹6.21 Cr (FY 2025)Active
Hi-Tech Multiplex Private Limited U45201OR2005PTC008409
Director18 Aug 20162005₹23.4 Lakh (FY 2025)Active
Konark Habitas Private Limited U45201OR1996PTC004302
Additional Director18 Aug 20161996₹14.8 Lakh (FY 2024)Active
Designated Partner05 Dec 20252025Active
Designated Partner28 Nov 20252025Active
Director15 Oct 20242024Active

Directorship timeline

Open interactive timeline →
Hi-Tech Edifice Private Limited
Hi-Tech Multiplex Private Limited
Prudent Security & Trading Private Limited
Mokshya Retails Private Limited
Premium access

Shareholding and investment profile for Pavan Kumar Ambati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pavan Kumar Ambati

Pavan Kumar Ambati currently holds 10 directorships: Biswa Pharmaceuticals Private Limited (Director, since 02 Aug 2018, revenue ₹18.36 Cr (FY 2024)); Mokshya Retails Private Limited (Director, since 18 May 2018, revenue ₹7.23 Cr (FY 2024)); Hi-Tech Edifice Private Limited (Director, since 18 Aug 2016, revenue ₹6.21 Cr (FY 2025)); Hi-Tech Multiplex Private Limited (Director, since 18 Aug 2016, revenue ₹23.4 Lakh (FY 2025)); Konark Habitas Private Limited (Additional Director, since 18 Aug 2016, revenue ₹14.8 Lakh (FY 2024)); and 5 more.

Pavan Kumar Ambati was first appointed on 18 Aug 2016 as Director at Hi-Tech Edifice Private Limited. The most recent appointment on record is 05 Dec 2025 at Reluxe Developers Llp.

The 5 current companies of Pavan Kumar Ambati that report revenue have a combined latest revenue of ₹32.19 Cr: Biswa Pharmaceuticals Private Limited ₹18.36 Cr (FY 2024); Mokshya Retails Private Limited ₹7.23 Cr (FY 2024); Hi-Tech Edifice Private Limited ₹6.21 Cr (FY 2025); Hi-Tech Multiplex Private Limited ₹23.4 Lakh (FY 2025); Konark Habitas Private Limited ₹14.8 Lakh (FY 2024).

The current boards of Pavan Kumar Ambati's companies include Ratikanta Panigrahi (Biswa Pharmaceuticals Private Limited), Susanth Kumar Satapathy (Biswa Pharmaceuticals Private Limited), Madhusmita Tripathy (Mokshya Retails Private Limited), Prafulla Kumar Mohanty (Hi-Tech Edifice Private Limited), Suryanarayana Chowdary (Hi-Tech Edifice Private Limited), Ashok Kumar Panigrahi (Konark Habitas Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available